Its all about shaping the future of coming new transformative therapy & treatments attended by the Electrome doctor who attended.
https://www.biospace.com/business/jpm26-bioph...to-execute
Interesting to read......."Wu expects deal size to remain relatively small, in the $5 billion to $20 billion range, with little appetite for transformative megadeals"
As for neuroscience, Suvannavejh noted that this sector remains an area of high interest—for biopharma companies, at least. “I do think that because of still unmet medical need, both on the neuropsychiatry side and also the neurodegenerative disease side, I think industry will continue to be very interested,” he said.
Check it out?
$TILLABELIEVER$$
https://www.biospace.com/business/jpm26-bioph...to-execute
Interesting to read......."Wu expects deal size to remain relatively small, in the $5 billion to $20 billion range, with little appetite for transformative megadeals"
As for neuroscience, Suvannavejh noted that this sector remains an area of high interest—for biopharma companies, at least. “I do think that because of still unmet medical need, both on the neuropsychiatry side and also the neurodegenerative disease side, I think industry will continue to be very interested,” he said.
Check it out?
$TILLABELIEVER$$
1
